ATE411033T1 - Formulierung zur behandlung von fettleibigkeit und assoziiertem stoffwechselsyndrom - Google Patents

Formulierung zur behandlung von fettleibigkeit und assoziiertem stoffwechselsyndrom

Info

Publication number
ATE411033T1
ATE411033T1 AT05700833T AT05700833T ATE411033T1 AT E411033 T1 ATE411033 T1 AT E411033T1 AT 05700833 T AT05700833 T AT 05700833T AT 05700833 T AT05700833 T AT 05700833T AT E411033 T1 ATE411033 T1 AT E411033T1
Authority
AT
Austria
Prior art keywords
formulation
obesity
extract
treatment
metabolic syndrome
Prior art date
Application number
AT05700833T
Other languages
English (en)
Inventor
Marcin Krotkiewski
Original Assignee
Scandinavian Clinical Nutritio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scandinavian Clinical Nutritio filed Critical Scandinavian Clinical Nutritio
Application granted granted Critical
Publication of ATE411033T1 publication Critical patent/ATE411033T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05700833T 2004-01-15 2005-01-12 Formulierung zur behandlung von fettleibigkeit und assoziiertem stoffwechselsyndrom ATE411033T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL364411A PL209905B1 (pl) 2004-01-15 2004-01-15 Preparat do leczenia otyłości i związanego z nią syndromu metabolicznego

Publications (1)

Publication Number Publication Date
ATE411033T1 true ATE411033T1 (de) 2008-10-15

Family

ID=34793496

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05700833T ATE411033T1 (de) 2004-01-15 2005-01-12 Formulierung zur behandlung von fettleibigkeit und assoziiertem stoffwechselsyndrom

Country Status (13)

Country Link
US (1) US20090175969A1 (de)
EP (1) EP1708726B1 (de)
JP (1) JP2007517830A (de)
KR (1) KR100826863B1 (de)
CN (1) CN1946415A (de)
AT (1) ATE411033T1 (de)
AU (1) AU2005205031A1 (de)
CA (1) CA2584191A1 (de)
DE (1) DE602005010387D1 (de)
NO (1) NO20063655L (de)
PL (1) PL209905B1 (de)
RU (1) RU2334523C2 (de)
WO (1) WO2005067952A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2883472B1 (fr) * 2005-03-23 2010-09-03 Rocher Yves Biolog Vegetale Utilisation d'un acide chlorogenique en tant qu'un actif amincissant
GB0520956D0 (en) 2005-10-14 2005-11-23 Med Eq As Chewing gum
EP2484345B1 (de) 2005-11-04 2014-02-26 InQpharm Group Sdn Bhd Kräuterzusammensetzung zur Gewichtsregelung
EP2001561A2 (de) * 2006-03-31 2008-12-17 DSMIP Assets B.V. Neue verwendung von verbindungen und kombinationen aus verbindungen zur verbesserung des physischen erscheinungsbildes
CA2666670A1 (en) 2006-10-20 2008-05-02 Dow Global Technologies Inc. Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome
CA2686419A1 (en) * 2007-05-04 2008-11-13 Nutraceutic Et Business Consulting Composition having lipolytic activity, production method thereof and use of the composition
RU2465787C1 (ru) * 2008-10-03 2012-11-10 СИГМА АЛИМЕНТОС, С.А. де К.В. Композиция, способствующая регуляции общего холестерина и холестерина лпнп, и/или потере веса, и/или термогенезу
KR20110066951A (ko) * 2008-10-03 2011-06-17 시그마 알리멘토스, 에스.에이. 데 씨. 브이. 총 및 ｌｄｌ 콜레스테롤의 제어 및/또는 체중 감량 및/또는 열발생을 촉진하기 위한 조성물
FR2938735B1 (fr) * 2008-11-21 2012-12-28 Holymark Composition amaigrissante, en particulier pour sportifs, administrable par voie orale et complement alimentaire integrant une telle composition.
KR20100124519A (ko) * 2009-05-19 2010-11-29 (주)아모레퍼시픽 녹차 추출물을 함유하는 조성물
CN102370589B (zh) * 2010-08-11 2013-02-13 迪特克(济源)绿色生物科技有限公司 一种减肥霜及其制备方法
JP5815566B2 (ja) 2011-01-21 2015-11-17 ライオン株式会社 脂肪分解促進用組成物
US20130177506A1 (en) * 2011-10-27 2013-07-11 Parker E. Atkins Bio-Available Chlorogenic Acid Preparations for Supplemental Human Consumption and Use
DE202014100439U1 (de) * 2014-01-17 2014-02-25 Pm-International Ag Pulverförmige Zusammensetzung zur Herstellung eines Nahrungsmittelersatzes
WO2016172717A1 (en) * 2015-04-24 2016-10-27 Grethe Stoa Birketvedt Plant extracts for the treatment of excess weight and obesity
CN107302997A (zh) * 2016-04-19 2017-10-31 林秀霞 一种抑制脂肪蓄积的组合物及其用途
CN107638569A (zh) * 2016-07-21 2018-01-30 上海聿健生物科技有限公司 增强褐色脂肪细胞产热效率的方法和应用
WO2018175417A1 (en) * 2017-03-21 2018-09-27 Pharmachem Laboratories, Llc Controlled release of phaseolamin compositions
MX2020009050A (es) * 2018-03-05 2021-01-15 Pure Care Pro Llc Productos y metodos de combinacion natural para la regulacion de la funcion del sistema renal y excretorio.
KR102267472B1 (ko) * 2018-10-24 2021-06-21 전남대학교산학협력단 녹차 카테킨을 포함하는 중성지방 저감용 식품 조성물, 대사성 질환 개선용 식품 조성물 및 대사성 질환 예방 또는 치료용 약학 조성물
CN113116955B (zh) * 2021-02-24 2022-10-04 中国药科大学 一种含植物提取物的药物组合物及其应用
JP2024008717A (ja) * 2022-07-08 2024-01-19 株式会社常磐植物化学研究所 カフェイン除去マテ抽出物、抗肥満用組成物、カフェイン除去方法及びマテ抽出物の製造方法
KR20240011314A (ko) 2022-07-19 2024-01-26 대구한의대학교산학협력단 과라나 추출물을 포함하는 지방 분화 유도 억제, 지방 합성 억제 및 혈장 콜레스테롤 생성 억제용 조성물, 약학 조성물 및 건강기능식품

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
FR2712191B1 (fr) * 1993-11-08 1996-03-08 Bioes Laboratoires Composition pharmaceutique ou diététique associant du ginseng et du guarana.
US5804596A (en) * 1997-02-27 1998-09-08 Sabinsa Corporation Method of preparing a forskohlin composition from forskohlin extract and use of forskohlin for promoting lean body mass and treating mood disorders
JPH10265328A (ja) * 1997-03-27 1998-10-06 Nippon Flour Mills Co Ltd 化粧料、ペットフード、リパーゼ阻害剤及びそれを含む食品
US6143301A (en) * 1998-08-28 2000-11-07 Ambi Inc. Chromium picolinate compositions and uses thereof
JP4783882B2 (ja) * 1999-11-17 2011-09-28 三邦株式会社 新規α−アミラーゼ阻害活性物質、その製造方法及びその用途
US6610749B2 (en) * 2000-02-18 2003-08-26 Arch Development Corporation Polyhydroxylated benzene-containing compounds
AU782378B2 (en) * 2000-04-04 2005-07-21 Color Access, Inc. Composition for improving skin lipid barrier function
JP4795511B2 (ja) * 2000-07-14 2011-10-19 日本サプリメント株式会社 α−グルコシダーゼ阻害剤の製造法
US6797287B2 (en) * 2001-09-25 2004-09-28 Pharmachem Laboratories, Inc. Phaseolamin compositions and methods for using the same
CA2478663A1 (en) * 2002-03-11 2003-09-18 General Nutrition Investment Company Methods for the treatment and prevention of overweight in mammals
CN1917892A (zh) * 2003-10-24 2007-02-21 草本制药科学有限责任公司 包含冬青的方法和组合物

Also Published As

Publication number Publication date
DE602005010387D1 (de) 2008-11-27
CA2584191A1 (en) 2005-07-28
KR20070009562A (ko) 2007-01-18
KR100826863B1 (ko) 2008-05-06
EP1708726B1 (de) 2008-10-15
US20090175969A1 (en) 2009-07-09
EP1708726A1 (de) 2006-10-11
PL209905B1 (pl) 2011-11-30
JP2007517830A (ja) 2007-07-05
RU2006129486A (ru) 2008-02-20
AU2005205031A1 (en) 2005-07-28
NO20063655L (no) 2006-09-22
WO2005067952A1 (en) 2005-07-28
PL364411A1 (en) 2005-07-25
WO2005067952A8 (en) 2005-11-03
RU2334523C2 (ru) 2008-09-27
CN1946415A (zh) 2007-04-11

Similar Documents

Publication Publication Date Title
ATE411033T1 (de) Formulierung zur behandlung von fettleibigkeit und assoziiertem stoffwechselsyndrom
EP3444242A3 (de) Neue benzopyran kinase inhibitoren
WO2009001362A3 (en) Herbal compositions for the treatment of diabetes and/or conditions associated therewith
HK1146485A1 (de)
BR112014008328A2 (pt) mecanismo de entrega nasal para uso profilático e pós-agudo de progesterona e/ou seu enantiômero para uso no tratamento de traumatismos crânio-encefálico leves
MY169564A (en) Substituted dihydropyrazolones and their use
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
DE502005005636D1 (en) Spirocyclische cyclohexan-derivate
IL179012A (en) A drug containing cetirizine for the treatment of nasal inflammation, a process for its preparation and use
UA100542C2 (ru) Способ лечения и/или профилактики синдрома слабоумия экстрактом, изготовленным из листьев ginkgo biloba
ZA201003794B (en) Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation
EP1942874A4 (de) Pflanzliche zusammensetzung zur beibehaltung des gewichts
NO20083307L (no) Anvendelse av et ikke-forsapbart ekstrakt fra plantemasse ved behandling av hudaldring
UA94461C2 (ru) Водный экстракт листьев табака и его применение для лечения состояния зависимости
PH12014501823A1 (en) Pharmaceutical composition for treating urinary incontinence and enuresis
WO2004098519A3 (en) Ginkgo biloba extract as a treatment for therapeutic­ induced neurotoxicity
BRPI0520221A2 (pt) uso de uma composiÇço nutriente que compreende polifenàis de chÁ verde para tratamento de osteossarcoma
WO2008130321A3 (en) Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
WO2010072774A3 (de) 5-ht2a und 5-ht2b rezeptorantagonisten zur behandlung der spinalkanalstenose
DK1962822T3 (da) Terapi af maligne neoplasier
WO2008110603A3 (en) Concentrate of protein c containing protein s, its preparation and use
MD2904F1 (en) Use of Gerovital H3 preparation for treatment of central nervous system affections to children
WO2009114462A3 (en) Local delivery of chemotherapeutic agents to skeletal metastases
WO2008144949A3 (de) Verwendung von marmor zu kosmetischen, pharmazeutischen und landwirtschaftlichen zwecken
WO2011093664A3 (ko) （１ｓ,２ｓ,３ｓ,４ｓ）-５- 아미노사이클로펜탄 - １,２,３,４- 테트라올을 포함하는 항비만 조성물.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties